SPDYE21

gene
On this page

Summary

SPDYE21 (speedy/RINGO cell cycle regulator family member E21, HGNC:51517) is a protein-coding gene on chromosome 7q11.21, encoding Speedy protein E21 (A0A494C086).

Predicted to enable protein kinase binding activity.

Source: NCBI Gene 442572 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_001382715

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:51517
Approved symbolSPDYE21
Namespeedy/RINGO cell cycle regulator family member E21
Location7q11.21
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000230358
Ensembl biotypeprotein_coding
Entrez442572

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000424157

RefSeq mRNA: 1 — MANE Select: NM_001382715 NM_001382715

CCDS: CCDS94109

Canonical transcript exons

ENST00000424157 — 9 exons

ExonStartEnd
ENSE000017090296728263567282693
ENSE000017586966728656067286664
ENSE000017637346727981867280036
ENSE000017794466728137467281604
ENSE000034837206728391367283998
ENSE000038457746727829267278873
ENSE000038460886728604467286437
ENSE000039349926727694167277062
ENSE000039355216728751867289005

Expression profiles

Bgee: expression breadth ubiquitous, 113 present calls, max score 77.52.

Top tissues by expression

121 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.52gold quality
bone marrow cellCL:000209258.02gold quality
bone marrowUBERON:000237155.22silver quality
tonsilUBERON:000237253.93silver quality
colonic epitheliumUBERON:000039752.48gold quality
adrenal tissueUBERON:001830350.80gold quality
lower esophagus mucosaUBERON:003583450.08gold quality
apex of heartUBERON:000209849.17gold quality
granulocyteCL:000009448.16silver quality
lymph nodeUBERON:000002947.70gold quality
uterine cervixUBERON:000000247.41gold quality
ectocervixUBERON:001224947.32gold quality
cortex of kidneyUBERON:000122547.20gold quality
smooth muscle tissueUBERON:000113547.08gold quality
left adrenal glandUBERON:000123446.89gold quality
testisUBERON:000047346.83gold quality
hindlimb stylopod muscleUBERON:000425246.72gold quality
kidneyUBERON:000211346.69gold quality
adrenal glandUBERON:000236946.52gold quality
left adrenal gland cortexUBERON:003582546.34gold quality
adult mammalian kidneyUBERON:000008246.18gold quality
left testisUBERON:000453346.02gold quality
urinary bladderUBERON:000125545.69silver quality
gastrocnemiusUBERON:000138845.23gold quality
right lobe of thyroid glandUBERON:000111945.10gold quality
bloodUBERON:000017845.00gold quality
right testisUBERON:000453444.97gold quality
stromal cell of endometriumCL:000225544.89gold quality
myometriumUBERON:000129644.81gold quality
muscle of legUBERON:000138344.72gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.77

Regulation

Is transcription factor: no

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
mus_musculusSpdye4bENSMUSG00000029586
mus_musculusSpdye4aENSMUSG00000039296
rattus_norvegicusSpdye4ENSRNOG00000058563

Paralogs (18): SPDYE1 (ENSG00000136206), SPDYE5 (ENSG00000170092), SPDYE2B (ENSG00000173678), SPDYE4 (ENSG00000183318), SPDYE12 (ENSG00000184616), SPDYE16 (ENSG00000185040), SPDYE17 (ENSG00000186645), SPDYE2 (ENSG00000205238), SPDYE18 (ENSG00000205482), SPDYE3 (ENSG00000214300), SPDYE6 (ENSG00000260097), SPDYE9 (ENSG00000262461), SPDYE8 (ENSG00000273520), SPDYE10 (ENSG00000274570), SPDYE11 (ENSG00000275976), SPDYE15 (ENSG00000286014), SPDYE13 (ENSG00000286038), SPDYE14 (ENSG00000286137)

Protein

Protein identifiers

Speedy protein E21A0A494C086 (reviewed: A0A494C086)

All UniProt accessions (1): A0A494C086

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the Speedy/Ringo family.

RefSeq proteins (1): NP_001369644* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR020984SpeedyFamily
IPR057742Speedy_EFamily

Pfam: PF11357

UniProt features (4 total): compositionally biased region 2, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A0A494C086-F160.840.19

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 2 (showing top): chr7q11, GOMF_KINASE_BINDING

GO Biological Process (1): positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)

GO Molecular Function (1): protein kinase binding (GO:0019901)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of cyclin-dependent protein serine/threonine kinase activity1
cyclin-dependent protein serine/threonine kinase activity1
positive regulation of cell cycle1
positive regulation of protein serine/threonine kinase activity1
positive regulation of cyclin-dependent protein kinase activity1
kinase binding1

Protein interactions and networks

STRING

4 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SPDYE21SPDYAQ5MJ700
SPDYE21SPDYCQ5MJ680

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A0J9YY54, A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NNV3, B4DH59, F6SZT2, P0C6Y7, P0CI01, P0DKJ7, P0DKJ8, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, P79386, Q08AG5, Q13342, Q16666, Q3BBV2, Q495Y8, Q587J8, Q5JRC9, Q5QGU6, Q5RD14, Q5RKG3, Q63HK3, Q6ITT4, Q7TQI8, Q86T75, Q8IWY8, Q8N660, Q8NFV5

Diamond homologs: A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NKU9, A6NLX3, A6NNV3, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, Q495Y7, Q495Y8, Q5IBH6, Q5IBH7, Q5MJ68, Q5MJ70, Q8NFV5, Q8R496, Q9PU13, Q9YGL1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

2649 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:67282655:T:CF211L0.978
7:67282657:C:AF211L0.978
7:67282657:C:GF211L0.978
7:67281589:T:CF199L0.970
7:67281591:C:AF199L0.970
7:67281591:C:GF199L0.970
7:67283940:T:CF233L0.959
7:67283942:C:AF233L0.959
7:67283942:C:GF233L0.959
7:67286086:A:CK266N0.951
7:67286086:A:TK266N0.951
7:67286102:T:CF272L0.949
7:67286104:C:AF272L0.949
7:67286104:C:GF272L0.949
7:67283988:T:CF249L0.948
7:67283990:C:AF249L0.948
7:67283990:C:GF249L0.948
7:67282656:T:CF211S0.942
7:67282668:A:TD215V0.902
7:67282668:A:CD215A0.900
7:67286085:A:TK266I0.899
7:67283985:T:CF248L0.898
7:67283987:C:AF248L0.898
7:67283987:C:GF248L0.898
7:67282666:G:CW214C0.897
7:67282666:G:TW214C0.897
7:67282667:G:CD215H0.881
7:67281590:T:CF199S0.879
7:67282638:A:GD205G0.878
7:67282639:T:AD205E0.877

dbSNP variants (sampled 300 via entrez): RS1001071444 (7:67281491 A>G,T), RS1001123750 (7:67280302 A>C), RS1001305551 (7:67288059 T>C), RS1001346610 (7:67288909 G>A), RS1003083438 (7:67276559 C>T), RS1004207200 (7:67276864 G>A), RS1004494358 (7:67275121 G>C), RS1005079182 (7:67283976 C>A,T), RS1005257401 (7:67278869 A>T), RS1005436569 (7:67284673 G>A), RS1005653076 (7:67286991 C>T), RS1005705177 (7:67286797 T>G), RS1005721294 (7:67278675 C>G), RS1006031665 (7:67286015 C>G,T), RS1006493592 (7:67285825 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
bisphenol Faffects cotreatment, decreases expression1
butyraldehydedecreases expression1
Dexamethasoneaffects cotreatment, decreases expression1
Indomethacinaffects cotreatment, decreases expression1
Tobacco Smoke Pollutiondecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.